We help UK and EU based Medical Device companies to maximise exit valuations by developing and commercialising products for the US marketplace representing 50% of Global Sales. In a marketplace with very different incentives to the European Healthcare model we address the fundamental challenges: How (much) will the device be reimbursed? What is the optimal route to approval? How do I address the needs of the US Healthcare system whilst also addressing the economic imperatives of all key… Show more We help UK and EU based Medical Device companies to maximise exit valuations by developing and commercialising products for the US marketplace representing 50% of Global Sales. In a marketplace with very different incentives to the European Healthcare model we address the fundamental challenges: How (much) will the device be reimbursed? What is the optimal route to approval? How do I address the needs of the US Healthcare system whilst also addressing the economic imperatives of all key stakeholders? How can I efficiently launch and build data for my product in the US market? Which physicians and sites should I target for endorsement (KOLs) and sales revenue?Select list of engagementsCamdiab, Cambridge UK Commercial Strategy Advisor for Hybrid Closed Loop Artificial Pancreas appCyted, Cambridge UKUS Go to Market Strategy for novel test for Barrett’s EsophagusGaitq, Oxford UKUS Go to Market Strategy for Wearable Cueing Device for Parkinson’sHealth Technology Accelerator Facility, Edinburgh UKUS Commercial Market Assessment for Confidence in Concept projectsLivanova, London UKInternational Distributor Distribution management post acquisition of Sleep Apnea Implantable and Cardiac Life Support assetsProthea Technologies, Edinburgh UKMarket Assessment for novel Lung Cancer Diagnosis and Treatment DeviceUSATherm, Miami USAHead of Product for 510k approved Vascular Thermography productVB Devices, Barcelona SpainUS Go to Market Advisor for Drug Device Sclerotherapy therapy for Varicose VeinsVeryan, London UKUS Market opportunity assessment for novel Vascular DeviceVicentra, Utrecht NetherlandsUK Launch Strategy for Kaleido Insulin Pump Show less

Planning US and EU launch strategy for Home Use Full Blood Count test for Immunocompromised patients receiving Systemic Anti-Cancer Therapies

Development of Phase III and IV Clinical Studies that realise near term Commercial value working with multi-functional teams including Regulatory, Clinical Development, Bio-Statistics, Med Affairs, CMC and IP.

Internation Commercial Expansion assessment and Strategy development ex-US: EU, Asia, South America and Canada.Leader of multi-functional project team for New Indications. Project lead across Regulatory, Clinical Development, Bio-Statistics, Med Affairs, Quality, CMC.

Market assessment and market entry strategy for Interventional Medicine NPD in International markets.

Sales, Commercial Operations and Business Development Consultancy for Medical Device SMEs involved in Start-up and Scale-up stages.Market Entry Strategy, Establishment of Direct Sales teams and Distribution partnerships, Recruitment Strategy, Route to Market, Sales Analytics, Sales Operations, Salesforce Effectiveness, CRM Implementation and Adoption, Use of Social Media, Customer Service and Inside Sales Strategies, Business Development and Financial Business Case development.

Responsible for multi-national commercial launch plan for the Cellnovo Mobile Diabetes Management System

Commercial Head of LifeScan Blood Glucose and Animas Insulin Pump BUs

Responsible for the Animas Insulin Pump business in the UK & Ireland. Project managed the transition of the business from a 3rd party distributor to full representation across all of the UK & Ireland. Responsible for Sales & Marketing functions and delivery of the P&L.